ADHD Medications Market, Global Outlook and Forecast 2022-2028

March 2022 | 66 pages | ID: A3018DDAE9BCEN
Market Monitor Global

Abstracts

ADHD medications can help reduce symptoms of hyperactivity, inattentiveness, and impulsivity in children and adults with attention deficit hyperactivity disorder (ADHD), formerly known as ADD.

This report contains market size and forecasts of ADHD Medications in Global, including the following market information:

Global ADHD Medications Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global ADHD Medications market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Stimulant Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of ADHD Medications include Amneal Pharmaceuticals, Eli Lilly and Co., Johnson and Johnson Services, NEOS Therapeutic, Takeda Pharmaceutical, Pfizer, Lupin, Shire and Mallinckrodt. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the ADHD Medications companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global ADHD Medications Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global ADHD Medications Market Segment Percentages, by Type, 2021 (%)

• Stimulant
• Non-stimulant

Global ADHD Medications Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global ADHD Medications Market Segment Percentages, by Application, 2021 (%)

• Adult
• Children

Global ADHD Medications Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global ADHD Medications Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies ADHD Medications revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies ADHD Medications revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Amneal Pharmaceuticals
• Eli Lilly and Co.
• Johnson and Johnson Services
• NEOS Therapeutic
• Takeda Pharmaceutical
• Pfizer
• Lupin
• Shire
• Mallinckrodt

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 ADHD Medications Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global ADHD Medications Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ADHD MEDICATIONS OVERALL MARKET SIZE

2.1 Global ADHD Medications Market Size: 2021 VS 2028
2.2 Global ADHD Medications Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top ADHD Medications Players in Global Market
3.2 Top Global ADHD Medications Companies Ranked by Revenue
3.3 Global ADHD Medications Revenue by Companies
3.4 Top 3 and Top 5 ADHD Medications Companies in Global Market, by Revenue in 2021
3.5 Global Companies ADHD Medications Product Type
3.6 Tier 1, Tier 2 and Tier 3 ADHD Medications Players in Global Market
  3.6.1 List of Global Tier 1 ADHD Medications Companies
  3.6.2 List of Global Tier 2 and Tier 3 ADHD Medications Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global ADHD Medications Market Size Markets, 2021 & 2028
  4.1.2 Stimulant
  4.1.3 Non-stimulant
4.2 By Type - Global ADHD Medications Revenue & Forecasts
  4.2.1 By Type - Global ADHD Medications Revenue, 2017-2022
  4.2.2 By Type - Global ADHD Medications Revenue, 2023-2028
  4.2.3 By Type - Global ADHD Medications Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global ADHD Medications Market Size, 2021 & 2028
  5.1.2 Adult
  5.1.3 Children
5.2 By Application - Global ADHD Medications Revenue & Forecasts
  5.2.1 By Application - Global ADHD Medications Revenue, 2017-2022
  5.2.2 By Application - Global ADHD Medications Revenue, 2023-2028
  5.2.3 By Application - Global ADHD Medications Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global ADHD Medications Market Size, 2021 & 2028
6.2 By Region - Global ADHD Medications Revenue & Forecasts
  6.2.1 By Region - Global ADHD Medications Revenue, 2017-2022
  6.2.2 By Region - Global ADHD Medications Revenue, 2023-2028
  6.2.3 By Region - Global ADHD Medications Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America ADHD Medications Revenue, 2017-2028
  6.3.2 US ADHD Medications Market Size, 2017-2028
  6.3.3 Canada ADHD Medications Market Size, 2017-2028
  6.3.4 Mexico ADHD Medications Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe ADHD Medications Revenue, 2017-2028
  6.4.2 Germany ADHD Medications Market Size, 2017-2028
  6.4.3 France ADHD Medications Market Size, 2017-2028
  6.4.4 U.K. ADHD Medications Market Size, 2017-2028
  6.4.5 Italy ADHD Medications Market Size, 2017-2028
  6.4.6 Russia ADHD Medications Market Size, 2017-2028
  6.4.7 Nordic Countries ADHD Medications Market Size, 2017-2028
  6.4.8 Benelux ADHD Medications Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia ADHD Medications Revenue, 2017-2028
  6.5.2 China ADHD Medications Market Size, 2017-2028
  6.5.3 Japan ADHD Medications Market Size, 2017-2028
  6.5.4 South Korea ADHD Medications Market Size, 2017-2028
  6.5.5 Southeast Asia ADHD Medications Market Size, 2017-2028
  6.5.6 India ADHD Medications Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America ADHD Medications Revenue, 2017-2028
  6.6.2 Brazil ADHD Medications Market Size, 2017-2028
  6.6.3 Argentina ADHD Medications Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa ADHD Medications Revenue, 2017-2028
  6.7.2 Turkey ADHD Medications Market Size, 2017-2028
  6.7.3 Israel ADHD Medications Market Size, 2017-2028
  6.7.4 Saudi Arabia ADHD Medications Market Size, 2017-2028
  6.7.5 UAE ADHD Medications Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Amneal Pharmaceuticals
  7.1.1 Amneal Pharmaceuticals Corporate Summary
  7.1.2 Amneal Pharmaceuticals Business Overview
  7.1.3 Amneal Pharmaceuticals ADHD Medications Major Product Offerings
  7.1.4 Amneal Pharmaceuticals ADHD Medications Revenue in Global Market (2017-2022)
  7.1.5 Amneal Pharmaceuticals Key News
7.2 Eli Lilly and Co.
  7.2.1 Eli Lilly and Co. Corporate Summary
  7.2.2 Eli Lilly and Co. Business Overview
  7.2.3 Eli Lilly and Co. ADHD Medications Major Product Offerings
  7.2.4 Eli Lilly and Co. ADHD Medications Revenue in Global Market (2017-2022)
  7.2.5 Eli Lilly and Co. Key News
7.3 Johnson and Johnson Services
  7.3.1 Johnson and Johnson Services Corporate Summary
  7.3.2 Johnson and Johnson Services Business Overview
  7.3.3 Johnson and Johnson Services ADHD Medications Major Product Offerings
  7.3.4 Johnson and Johnson Services ADHD Medications Revenue in Global Market (2017-2022)
  7.3.5 Johnson and Johnson Services Key News
7.4 NEOS Therapeutic
  7.4.1 NEOS Therapeutic Corporate Summary
  7.4.2 NEOS Therapeutic Business Overview
  7.4.3 NEOS Therapeutic ADHD Medications Major Product Offerings
  7.4.4 NEOS Therapeutic ADHD Medications Revenue in Global Market (2017-2022)
  7.4.5 NEOS Therapeutic Key News
7.5 Takeda Pharmaceutical
  7.5.1 Takeda Pharmaceutical Corporate Summary
  7.5.2 Takeda Pharmaceutical Business Overview
  7.5.3 Takeda Pharmaceutical ADHD Medications Major Product Offerings
  7.5.4 Takeda Pharmaceutical ADHD Medications Revenue in Global Market (2017-2022)
  7.5.5 Takeda Pharmaceutical Key News
7.6 Pfizer
  7.6.1 Pfizer Corporate Summary
  7.6.2 Pfizer Business Overview
  7.6.3 Pfizer ADHD Medications Major Product Offerings
  7.6.4 Pfizer ADHD Medications Revenue in Global Market (2017-2022)
  7.6.5 Pfizer Key News
7.7 Lupin
  7.7.1 Lupin Corporate Summary
  7.7.2 Lupin Business Overview
  7.7.3 Lupin ADHD Medications Major Product Offerings
  7.7.4 Lupin ADHD Medications Revenue in Global Market (2017-2022)
  7.7.5 Lupin Key News
7.8 Shire
  7.8.1 Shire Corporate Summary
  7.8.2 Shire Business Overview
  7.8.3 Shire ADHD Medications Major Product Offerings
  7.8.4 Shire ADHD Medications Revenue in Global Market (2017-2022)
  7.8.5 Shire Key News
7.9 Mallinckrodt
  7.9.1 Mallinckrodt Corporate Summary
  7.9.2 Mallinckrodt Business Overview
  7.9.3 Mallinckrodt ADHD Medications Major Product Offerings
  7.9.4 Mallinckrodt ADHD Medications Revenue in Global Market (2017-2022)
  7.9.5 Mallinckrodt Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. ADHD Medications Market Opportunities & Trends in Global Market
Table 2. ADHD Medications Market Drivers in Global Market
Table 3. ADHD Medications Market Restraints in Global Market
Table 4. Key Players of ADHD Medications in Global Market
Table 5. Top ADHD Medications Players in Global Market, Ranking by Revenue (2021)
Table 6. Global ADHD Medications Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global ADHD Medications Revenue Share by Companies, 2017-2022
Table 8. Global Companies ADHD Medications Product Type
Table 9. List of Global Tier 1 ADHD Medications Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 ADHD Medications Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global ADHD Medications Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - ADHD Medications Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - ADHD Medications Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global ADHD Medications Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - ADHD Medications Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - ADHD Medications Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global ADHD Medications Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global ADHD Medications Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global ADHD Medications Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America ADHD Medications Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America ADHD Medications Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe ADHD Medications Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe ADHD Medications Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia ADHD Medications Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia ADHD Medications Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America ADHD Medications Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America ADHD Medications Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa ADHD Medications Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa ADHD Medications Revenue, (US$, Mn), 2023-2028
Table 30. Amneal Pharmaceuticals Corporate Summary
Table 31. Amneal Pharmaceuticals ADHD Medications Product Offerings
Table 32. Amneal Pharmaceuticals ADHD Medications Revenue (US$, Mn), (2017-2022)
Table 33. Eli Lilly and Co. Corporate Summary
Table 34. Eli Lilly and Co. ADHD Medications Product Offerings
Table 35. Eli Lilly and Co. ADHD Medications Revenue (US$, Mn), (2017-2022)
Table 36. Johnson and Johnson Services Corporate Summary
Table 37. Johnson and Johnson Services ADHD Medications Product Offerings
Table 38. Johnson and Johnson Services ADHD Medications Revenue (US$, Mn), (2017-2022)
Table 39. NEOS Therapeutic Corporate Summary
Table 40. NEOS Therapeutic ADHD Medications Product Offerings
Table 41. NEOS Therapeutic ADHD Medications Revenue (US$, Mn), (2017-2022)
Table 42. Takeda Pharmaceutical Corporate Summary
Table 43. Takeda Pharmaceutical ADHD Medications Product Offerings
Table 44. Takeda Pharmaceutical ADHD Medications Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer ADHD Medications Product Offerings
Table 47. Pfizer ADHD Medications Revenue (US$, Mn), (2017-2022)
Table 48. Lupin Corporate Summary
Table 49. Lupin ADHD Medications Product Offerings
Table 50. Lupin ADHD Medications Revenue (US$, Mn), (2017-2022)
Table 51. Shire Corporate Summary
Table 52. Shire ADHD Medications Product Offerings
Table 53. Shire ADHD Medications Revenue (US$, Mn), (2017-2022)
Table 54. Mallinckrodt Corporate Summary
Table 55. Mallinckrodt ADHD Medications Product Offerings
Table 56. Mallinckrodt ADHD Medications Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. ADHD Medications Segment by Type in 2021
Figure 2. ADHD Medications Segment by Application in 2021
Figure 3. Global ADHD Medications Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global ADHD Medications Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global ADHD Medications Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by ADHD Medications Revenue in 2021
Figure 8. By Type - Global ADHD Medications Revenue Market Share, 2017-2028
Figure 9. By Application - Global ADHD Medications Revenue Market Share, 2017-2028
Figure 10. By Region - Global ADHD Medications Revenue Market Share, 2017-2028
Figure 11. By Country - North America ADHD Medications Revenue Market Share, 2017-2028
Figure 12. US ADHD Medications Revenue, (US$, Mn), 2017-2028
Figure 13. Canada ADHD Medications Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico ADHD Medications Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe ADHD Medications Revenue Market Share, 2017-2028
Figure 16. Germany ADHD Medications Revenue, (US$, Mn), 2017-2028
Figure 17. France ADHD Medications Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. ADHD Medications Revenue, (US$, Mn), 2017-2028
Figure 19. Italy ADHD Medications Revenue, (US$, Mn), 2017-2028
Figure 20. Russia ADHD Medications Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries ADHD Medications Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux ADHD Medications Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia ADHD Medications Revenue Market Share, 2017-2028
Figure 24. China ADHD Medications Revenue, (US$, Mn), 2017-2028
Figure 25. Japan ADHD Medications Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea ADHD Medications Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia ADHD Medications Revenue, (US$, Mn), 2017-2028
Figure 28. India ADHD Medications Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America ADHD Medications Revenue Market Share, 2017-2028
Figure 30. Brazil ADHD Medications Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina ADHD Medications Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa ADHD Medications Revenue Market Share, 2017-2028
Figure 33. Turkey ADHD Medications Revenue, (US$, Mn), 2017-2028
Figure 34. Israel ADHD Medications Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia ADHD Medications Revenue, (US$, Mn), 2017-2028
Figure 36. UAE ADHD Medications Revenue, (US$, Mn), 2017-2028
Figure 37. Amneal Pharmaceuticals ADHD Medications Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Eli Lilly and Co. ADHD Medications Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Johnson and Johnson Services ADHD Medications Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. NEOS Therapeutic ADHD Medications Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Takeda Pharmaceutical ADHD Medications Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer ADHD Medications Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Lupin ADHD Medications Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Shire ADHD Medications Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Mallinckrodt ADHD Medications Revenue Year Over Year Growth (US$, Mn) & (2017-2022)